NCT02263833 An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice Status COMPLETED Phase N/A
NCT02263079 A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase Status COMPLETED Phase PHASE3
NCT02257567 A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT02254759 A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants Status COMPLETED Phase PHASE1
NCT02252887 Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy Status COMPLETED Phase PHASE2
NCT02251860 Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice Status COMPLETED Phase N/A
NCT02247531 A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status TERMINATED Phase PHASE3
NCT02247479 A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status TERMINATED Phase PHASE3
NCT02242942 Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT02240355 A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH) Status TERMINATED Phase PHASE1
NCT02240316 An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice Status COMPLETED Phase N/A
NCT02238080 An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis Status COMPLETED Phase N/A
NCT02238067 Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis Status COMPLETED Phase N/A
NCT02234960 Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase N/A
NCT02228668 Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon Carcinoma Status COMPLETED Phase N/A
NCT02220842 A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE1
NCT02205073 A Phase 1, Randomized, Double-blind, Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants: Proof of Mechanism Status COMPLETED Phase PHASE1
NCT02204345 A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology Status TERMINATED Phase PHASE1/PHASE2
NCT02201407 An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study Status COMPLETED Phase N/A
NCT02199288 Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life Setting Status COMPLETED Phase N/A